Position
Parallel Advisors, LLC in Larimar Therapeutics, Inc.
Back to the book · All holders of LRMR
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $134$3.81 → $4.50
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 193 | $735 | — | — | — | 0.0% |
| Q1 2026 | 193 | $869 | $4.50 | $134 | $0 | 0.0% |